Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
1938 • 19,183 citations
A simple method of estimating 50 per cent end points
1938 • 8,381 citations
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
1987 • 3,000 citations
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
1985 • 1,830 citations
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
1986 • 1,348 citations
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
1990 • 1,288 citations
Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons
1989 • 1,090 citations
Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection
1991 • 851 citations
Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis
1988 • 366 citations
Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals
1990 • 131 citations
Management of Occupational Exposures to Bloodborne Pathogens: Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus
1992 • 86 citations
Nonhuman Primate Models for Evaluation of AIDS Therapya
1990 • 67 citations
Simian and feline immunodeficiency viruses: Animal lentivirus models for evaluation of AIDS vaccines and antiviral agents
1991 • 66 citations
Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-alpha: failure after inoculating rhesus monkeys with a high dose of SIV.
1991 • 55 citations
Efficacy of live‐attenuated and whole‐inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV
1992 • 55 citations
Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay
1991 • 52 citations
Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus.
1991 • 46 citations
Quantitation of human immunodeficiency virus in vertically infected infants and children
1991 • 43 citations
Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccines in Infant Rhesus Monkeys
1991 • 31 citations
Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques
1992 • 28 citations
Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate.
1990 • 27 citations
Simple and rapid high-performance liquid chromatographic assay for zidovudine (azidothymidine) in plasma and urine
1988 • 26 citations
Quantitation of HIV: Correlation with clinical, virological, and immunological status
1991 • 25 citations
Specific routine determination of 3'-azido-3'-deoxythymidine (AZT) in plasma by partly automated liquid chromatography.
1989 • 21 citations
In Vitro Testing of Therapeutics against SIV and HIV
1990 • 3 citations